Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2010
12/30/2010US20100331294 4-substituted-2-amino-pyrimidine derivatives
12/30/2010US20100331287 6-(Aminoalkyl)Indazoles
12/30/2010US20100331285 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100331280 Modulation of the Phospholipase A2 Pathway as a Therapeutic
12/30/2010US20100331271 Use of Acacetin and Related Compounds as Potassium Channel Inhibitors
12/30/2010US20100331270 Adrenomedullin production enhancer
12/30/2010US20100331268 Nitrated Lipids and Methods of Making and Using Thereof
12/30/2010US20100331251 Polypeptides homologous to vegf and bmp1
12/30/2010US20100331239 Cd14 and peptides thereof for protection of cells against cell death
12/30/2010US20100331238 Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression
12/30/2010US20100331236 Cyclic peptides as g-protein coupled receptor antagonists
12/30/2010US20100331234 Aminoalcohol lipidoids and uses thereof
12/30/2010US20100330673 Methods of making enhanced, autologous fat grafts
12/30/2010US20100330668 Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto
12/30/2010US20100330211 Fucoidan compositions and methods for dietary and nutritional supplements
12/30/2010US20100330210 Ghrelin production promoter
12/30/2010US20100330206 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
12/30/2010US20100330193 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
12/30/2010US20100330174 Betaine compositions
12/30/2010US20100330157 Biomaterial for the controlled delivery of ingredients
12/30/2010US20100330150 Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
12/30/2010US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c
12/30/2010US20100330108 Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
12/30/2010US20100330096 Methods of treating diseases with anti-vegf antibodies
12/30/2010US20100330090 Antagonist antibodies of protease activated receptor-1 (par1)
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330064 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
12/30/2010US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
12/30/2010US20100330050 Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
12/30/2010US20100330047 Mesenchymal Stem Cells Grown Under Hypoxic Conditions: Compositions, Methods and Uses Therefor
12/30/2010US20100330044 Mesp1 as a master regulator of multipotent cardiovascular progenitor specification and uses thereof
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases
12/30/2010US20100329984 Respiratory dispersion for metered dose inhalers
12/30/2010US20100329976 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2010WO2010151160A1 O-substituted 3-n-heteroaryl-1,3,4-oxadiazolones for medical use
12/29/2010WO2010151096A1 Therapeutic combinations of nicotinic acid and meldonium
12/29/2010WO2010151095A1 Novel acetylsalicylic acid salts
12/29/2010WO2010151080A2 Pharmaceutical composition containing carboxylosartan and a production method therefor
12/29/2010WO2010151004A2 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
12/29/2010WO2010150921A1 Therapeutic agent for hypertension or normal high blood pressure
12/29/2010WO2010150899A1 Novel thiophene carboxamide derivative and medicinal use of same
12/29/2010WO2010150865A1 Crystals
12/29/2010WO2010150840A1 N-substituted-cyclic amino derivative
12/29/2010WO2010150819A1 Therapeutic agent for ischemic cerebrovascular disorders
12/29/2010WO2010150739A1 Hydroxyl-containing pyripyropene derivatives exhibiting acat2-inhibitory activity
12/29/2010WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state
12/29/2010WO2010150538A1 Drug for inhibiting lectin-like oxidized ldl receptor and drug for preventing arteriosclerosis
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150079A1 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis
12/29/2010WO2010149888A1 Derivatives of 2-mercaptocyclopentane carboxylic acid, method for the preparation thereof, and pharmaceutical compositions containing the same
12/29/2010WO2010149815A1 Olive-oil-based functional oils
12/29/2010WO2010149658A2 Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
12/29/2010WO2010149654A1 Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
12/29/2010WO2010149653A1 A pharmaceutical composition comprising meldonium succinate and medical uses thereof
12/29/2010WO2010121207A9 Methods and compositions related to the interaction of t-cadherin and adiponectin
12/29/2010WO2010078730A9 Preparation of ginsenoside-rd propylene glycol aqueous solution and new use thereof in anti-inflammation, immunosuppression and anti organ-graft rejection
12/29/2010WO2010072327A3 Pharmaceutical composition based on peptide from camel milk
12/29/2010WO2010062557A8 Multimodal imaging of atherosclerotic plaque targeted to lox-1
12/29/2010EP2267031A1 Endothelial cell specific antibodies and uses thereof
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2266990A1 3-PHENYLPYRAZOLOÝ5,1-b¨THIAZOLE COMPOUND
12/29/2010EP2266989A2 Heterocyclic derivatives
12/29/2010EP2266978A1 Novel physiologically active substances
12/29/2010EP2266962A1 The compounds as the estrogen related receptors modulators and the uses thereof
12/29/2010EP2266960A2 Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants
12/29/2010EP2266951A1 Organic compounds
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266589A1 Ganoderma tsugae active substance having endothelial cell-protecting and atherosclerosis-preventing effects, process for preparing the same and composition containing the same
12/29/2010EP2266575A2 Use of Norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels
12/29/2010EP2266570A1 Use of binding partners for 5-HT5 receptors for treating neurodegenerative and neuropsychiatric disorders
12/29/2010EP2266540A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
12/29/2010EP2266502A1 Apparatus for stenting with enhanced protection against embolism, restenosis and thrombus formation
12/29/2010EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
12/29/2010EP2265591A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
12/29/2010EP2265584A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity
12/29/2010EP2265114A2 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling
12/29/2010EP1951251B1 Spirohydantoin aryl cgrp receptor antagonists
12/29/2010EP1881985B1 Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
12/29/2010EP1599503B1 Endothelial cell specific antibodies and uses thereof
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010EP1107722B1 A method for the treatment of staphylococcal infection
12/29/2010EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN1902196B Thiazole derivative
12/29/2010CN1856504B Anti-infarction molecules
12/29/2010CN101932586A Inhibitors of protein tyrosine kinase activity
12/29/2010CN101932551A Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
12/29/2010CN101932332A Labisia pumila extracts for reducing the risk of cardiovascular diseases
12/29/2010CN101928739A New preparation method of high-density lipoprotein
12/29/2010CN101928320A American ginseng ginsenoside F5ab and extraction method and medicinal application thereof
12/29/2010CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
12/29/2010CN101928280A Pepperphentonamine derivative containing naphthalene rings
1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 1595